Shanghai, China

Rui Jin

This inventor holds 2 USPTO granted patents. Top assignees: Bliss Biopharmaceutical (Hangzhou) Co., Ltd., Chinese Academy of Sciences, Fudan University. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rui Jin. Retrieved from https://idiyas.com/inventor/rui-jin-et9tg2vi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.7

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Rui JIN

Introduction: Rui JIN is a renowned inventor based in Shanghai, China, known for his groundbreaking innovations in various fields.

Latest Patents: Rui JIN holds several patents in the areas of technology and engineering, with his most recent inventions focusing on sustainable energy solutions and advanced robotics.

Career Highlights: Throughout his career, Rui JIN has demonstrated a strong commitment to pushing the boundaries of technological advancement. His work has been instrumental in shaping the future of industries such as renewable energy, artificial intelligence, and biotechnology.

Collaborations: Rui JIN has collaborated with leading research institutions, universities, and multinational companies to further develop and commercialize his inventions. His partnerships have resulted in the successful implementation of cutting-edge technologies in real-world applications.

Conclusion: Inventor Rui JIN's passion for innovation and his dedication to creating impactful solutions have solidified his reputation as a visionary in the world of technology. His contributions continue to inspire the next generation of inventors and shape the landscape of innovation globally.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…